VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2021 | CMV-specific immunoglobulins for transplant patients

Javier Carbone, MD, Hospital General Universitario Gregorio Marañón, Madrid, Spain, discusses the immunological benefits of cytomegalovirus (CMV)-specific immunoglobulins. Dr Carbone describes how these products can increase anti-CMV cellular responses and their significance during the COVID-19 pandemic. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Javier Carbone, MD, has received payment from Biotest for this activity.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter